In Segment A, members will acquire diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing program. Further members will be enrolled with the discovered monotherapy dosign program. In Segment B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section https://judahbnyit.iyublog.com/31282921/a-review-of-abbv-744-in-combination-with-immunotherapy